Follow The Filings

ATCH AtlasClear

AtlasClear earnings company data as of 4:47 AM ET 10/22

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 30 Sep EPS -0.02 — —
Rev $5.8M — —

Insider trades

Open-market buys and sales by ATCH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ATCH insider trades
  • $163K bought by 5 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. John Martin Schaible Chair
    Buy
    $20K 100,000 shares at $0.2000 +10% to stake
    Traded Sep 24–25 Filed Sep 28
    ↗
  2. David Craig Ridenhour President
    Buy
    $19K 100,000 shares at $0.1900 +10% to stake
    Traded Sep 24–25 Filed Sep 28
    ↗
  3. Sandip I Patel CFO
    Buy
    $21K 100,000 shares at $0.2100 +12% to stake
    Traded Sep 24–25 Filed Sep 28
    ↗
  4. Thomas Jon Hammond Director
    Buy
    $100K 500,000 shares at $0.2000 +70822% to stake
    Traded Sep 24 Filed Sep 28
    ↗
  5. Steven J. Carlson Director
    Buy
    $2,945 15,000 shares at $0.2000 New stake
    Traded Sep 24–25 Filed Sep 28
    ↗

Also filed in the last 12 months, not counted as buying or selling: 13 stock grants.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 1.01,2.03,3.02,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01 Filing Doc
DEFA14A Filing Doc
DEF 14A Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,2.03,3.02,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
S-1/A Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
S-1 Filing Doc
8-K 2.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.